This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Prognostic Potential of Cell Surface Markers and P...
Clinical trial

Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma

Read time: 1 mins
Last updated:13th Jul 2011
The purpose of this study is to understand if small proteins found on the surface of myeloma cells (called CXCR4, CD47, and beta 2 adrenergic receptors) can predict how patients will respond to chemotherapy-treatment and if a small molecule inside the myeloma cells (called Pim kinase) can be used as a treatment target for myeloma.
Category Value
Study start date 2011-07-13

View full details